“Digoxin toxicity”的搜索结果，显示 531-540 项，共有 11869 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... toxicity. Patient demographics, adverse events, and comorbidities will also be collected via survey and/or medical record review. A selected subset of ...

2. 外科 - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to characterize the safety, dose limiting toxicities (DLTs), maximum tolerated dose (MTD), maximum administered ...

3. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... toxicity. Patient demographics, adverse events, and comorbidities will also be collected via survey and/or medical record review. A selected subset of ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. ... toxicity. Patient demographics, adverse events, and comorbidities will ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... toxicities [DLTs] and the total toxicity profile. The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Key secondary endpoints are toxicity, end-Induction response, and overall survival. ... toxicity. Patient demographics, adverse events, and comorbidities will ...

8. 血液科- 临床试验- 妙佑医疗国际

   ... toxicity. Patient demographics, adverse events, and comorbidities will also be collected via survey and/or medical record review. A selected subset of ...

9. 临床试验- 妙佑医疗国际儿童中心

   The purpose of this study is to study the length of the QTc interval in patients receiving the standard of care dose of intravenous droperidol for headache ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... toxicity. Patient demographics, adverse events, and comorbidities will also be collected via survey and/or medical record review. A selected subset of ...